Deletion of a Small Consensus Region at 6q15, Including theMAP3K7Gene, Is Significantly Associated with High-Grade Prostate Cancers
Open Access
- 1 September 2007
- journal article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 13 (17) , 5028-5033
- https://doi.org/10.1158/1078-0432.ccr-07-0300
Abstract
Purpose: Chromosome 6q14-21 is commonly deleted in prostate cancers, occurring in ∼22% of all tumors and ∼40% of metastatic tumors. However, candidate prostate tumor suppressor genes in this region have not been identified, in part due to the large and broad nature of the deleted region implicated in previous studies. Experimental Design: We first used high-resolution Affymetrix single nucleotide polymorphism arrays to examine DNA from malignant and matched nonmalignant cells from 55 prostate cancer patients. We identified a small consensus region on 6q14-21 and evaluated the deletion status within the region among additional 40 tumors and normal pairs using quantitative PCR and fluorescence in situ hybridization. We finally tested the association between the deletion and Gleason score using the Fisher's exact test. Results: Tumors with small, interstitial deletions at 6q14-21 defined an 817-kb consensus region that is affected in 20 of 21 tumors. The MAP3K7 gene is one of five genes located in this region. In total, MAP3K7 was deleted in 32% of 95 tumors. Importantly, deletion of MAP3K7 was highly associated with higher-grade disease, occurring in 61% of tumors with Gleason score ≥8 compared with only 22% of tumors with Gleason score ≤7. The difference was highly significant (P = 0.001). Conclusion: Our study provides strong evidence for the first time that a small deletion at 6q15, including the MAP3K7 gene and four other genes, is associated with high-grade prostate cancers. Although the deletion may be a marker for high-grade prostate cancer, additional studies are needed to understand its molecular mechanisms.Keywords
This publication has 12 references indexed in Scilit:
- DNA copy number alterations in prostate cancers: A combined analysis of published CGH studiesThe Prostate, 2007
- Comprehensive assessment of DNA copy number alterations in human prostate cancers using Affymetrix 100K SNP mapping arrayGenes, Chromosomes and Cancer, 2006
- TGF-β and cancerPublished by Elsevier ,2005
- A Robust Algorithm for Copy Number Detection Using High-Density Oligonucleotide Single Nucleotide Polymorphism Genotyping ArraysCancer Research, 2005
- dChipSNP: significance curve and clustering of SNP-array-based loss-of-heterozygosity dataBioinformatics, 2004
- Genetic mapping of allelic loss on chromosome 6q within heterogeneous prostate carcinomaCancer Science, 2003
- Representational Oligonucleotide Microarray Analysis: A High-Resolution Method to Detect Genome Copy Number VariationGenome Research, 2003
- Defining the region(s) of deletion at 6q16–q22 in human prostate cancerGenes, Chromosomes and Cancer, 2002
- Physical Mapping of Chromosome 8p22 Markers and Their Homozygous Deletion in a Metastatic Prostate CancerGenomics, 1996
- Identification of a Member of the MAPKKK Family as a Potential Mediator of TGF-β Signal TransductionScience, 1995